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Abstract
Strategies to achieve controlled nanoparticle aggregation have gained much interest, due to the versatility of such systems and their
applications in materials science and medicine. In this article we demonstrate that coiled-coil peptide-induced aggregation based on
electrostatic interactions is highly sensitive to the length of the peptide as well as the number of presented charges. The quaternary
structure of the peptide was found to play an important role in aggregation kinetics. Furthermore, we show that the presence of
peptide fibers leads to well-defined nanoparticle assembly on the surface of these macrostructures.
Introduction
In the past few decades metal and semiconductor nanoparticles,
including gold nanoparticles, have gained much interest due to
their desirable optical, magnetic, and electronic properties [1].
In particular, the distinct colour of gold nanoparticles is a result
of the localised surface plasmon resonance (LSPR) band caused
by collective electron oscillations. The LSPR induces a certain
excitation band at visible wavelengths in the absorption spec-
trum, the position and width of which is highly dependent upon
nanoparticle size. However, nanoparticle aggregation induces a
spectral red-shift and broadening of the band in the absorption
spectrum which depends on the distance between nanoparticles,
the density of the assembly and the size of the particles [2,3].
Thus the controlled assembly of nanoparticles by means of
biomolecules is crucial for biological and medical applications
such as sensing [4], bioimaging [5], and medical diagnostics
[6]. Although nanoparticles are also applied as targeted
biomarkers and drug-delivery agents to tumor cells [7], only
very little is known about the effects of nanoparticles on whole
organisms [8].
Furthermore, there is great interest in using biomolecules as
components to build up self-assembled supramolecular
organic–inorganic hybrid materials for engineering novel func-
tional materials and molecular devices [9,10]. In spite of the
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increasing demand for smaller, more complex, but even cheaper
materials, the commonly used “top-down” methods are not
available. Thus, new strategies like the “bottom-up” approach
have been developed to achieve materials in the nanometer
range [11,12]. This technique is based on the self-assembly of
small building blocks to construct functional materials by
means of biomolecules. Recent studies have made use of DNA,
lipids, peptides, and proteins to build up organic–inorganic
hybrid materials [9]. Due to their versatile and unique function-
alities, which can be used for catalytic [13], optics [14], and
switching [15] applications, a variety of specific and site selec-
tive binding properties are available [16]. In particular, the
specificity of Watson–Crick base pairing of DNA nucleotides
can be used for the directed and predictable self-assembly of
nanoparticles [17]. The DNA mediated assembly of nano-
particles is realized in two different ways. In the first regime,
two sets of nanoparticles are functionalized with complemen-
tary single-stranded DNA sequences which then anneal to one
another [18]; in an alternative setup, adding a complementary
linker to nanoparticles functionalised with single-stranded DNA
can drive the assembly to form extended networks [19].
Although the relationship between the primary and quaternary
structures of peptides and proteins are less clear than for DNA,
protein-based recognition systems containing antigen–antibody
[20], biotin–streptavidin [21], and peptide–peptide [22] interac-
tions have been explored. In particular, peptide-based assem-
blies afford numerous advantages such as the modification of
nanostructures by mutations of the primary sequence of
peptides which may lead to the formation of various hierar-
chical morphologies [23-25]. The strategies for the assembly of
nanoparticles are very similar to those for DNA. Either one part
of the recognition system is directly bound to the surface of the
nanoparticle by a disulfide bond and the addition of a linker
induces assembly, or both linker and acceptor are immobilised
on the surface of different nanoparticles and induce assembly
[9]. Peptide-based nanoparticle aggregation was demonstrated
first by Woolfson and coworkers by means of coiled-coil
peptides that were immobilized on the nanoparticle surface
[26].
Reversibility of the assembly formation, a key feature of a
switchable system, has thus far been explored only for a few
nanoparticle systems by means of temperature [19]; most of the
assemblies are irreversibly formed [9], or reversibility is only
achieved by adding, for example, oxidizing reagents [27].
Continuous switch behaviour between aggregated and non-
aggregated nanoparticles is not obtained as the formation of
assemblies is most likely achieved by hydrogen bonds or other
common receptor–binding interactions [28]. Although it is
known that nanoparticles can be organised by binding to
membranes by means of electrostatic interactions between the
charged head group of the lipid and the oppositely charged
nanoparticle [29], only limited effort has been put forth to use
peptides or proteins to organize nanoparticles by electrostatic
interactions [30,31]. As the overall net charge of a peptide is pH
dependent, this can be a powerful tool for the controlled and re-
versible assembly of nanoparticles.
Recently we published the use of coiled-coil model peptide
VW05 for the reversible assembly of mercaptoundecanoic acid
functionalized gold nanoparticles using electrostatic interac-
tions [32,33]. We showed that the interaction can be repeatedly
switched by adjusting the pH value. We further demonstrated
that the ability of the peptide to interact with nanoparticles is
directly related to its helical structure and the resulting local
charge at the solvent-exposed face of the coiled-coil: a control
peptide with the same amino acid composition, which did not
follow the regular heptad repeat, was not able to organize nano-
particles in networks. Thus, the electrostatic interaction is not
only determined by the overall net charge of the peptide but
requires defined spatial ordering and regularity.
Here we report the use of modified peptide variants of the
previously studied VW05 for the controlled assembly of
gold nanoparticles. As the assembly of charged gold nano-
particles depends on the local charge of the coiled-coil in a
multivalent fashion, we wanted to study different aspects of
nanoparticle–peptide interactions such as the aggregation ten-
dency of the peptide and the morphology of the obtained
peptide–nanoparticle assemblies.
Results
Design of the model peptides
The α-helical coiled-coil folding motif combines the chemical
diversity of peptides with the molecular recognition properties
and structural stability of DNA, and provides a valuable and
variable system for the organisation of functionalized nano-
particles [34-36].
The coiled-coil folding motif consists of two to seven α-helices
that are wrapped around each other to form a left-handed super-
coil. The primary sequence consists of a regular pattern of
seven amino acids denoted with a, b, c, d, e, f, and g, which is
referred to as the heptad repeat. Positions a and d are commonly
occupied by nonpolar amino acids such as leucine or valine to
form the hydrophobic core which represents one recognition
domain. Amino acids in e and g positions, which flank the
hydrophobic core, are often charged and form a second recogni-
tion domain due to complementary interhelical electrostatic
interactions between the helices. Both recognition domains
drive the formation of the coiled-coil, thus they are responsible
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Figure 1: Helical wheel representation and sequences of the peptides used in this study.
for the thermodynamic stability of this quaternary structure.
Positions b, c, and f, on the other hand, are solvent-exposed and
exert only a minor influence on the coiled-coil structure and
stability. They are mainly occupied by hydrophilic amino acids
and therefore play an important role in interactions with other
molecules in the surrounding environment.
In a previous study we showed that the coiled-coil model
peptide VW05 induces controlled aggregation of charged gold
nanoparticles. The overall primary sequence of VW05 was
designed to provide a pH-responsive aggregation of nano-
particles based on electrostatic interactions. Accordingly, a
scrambled version of VW05 with the same amino acid compos-
ition and net charge did not show any evidence for electrostatic
interactions with the nanoparticles and did not trigger nanopar-
ticle aggregation. Thus, it was concluded that the observed
nanoparticle–peptide aggregate formation results from the well-
defined presentation of four arginine residues in f-positions of
the coiled-coil motif [32].
In the current study we investigate in detail the effect of the
number of presented charges on the aggregation of VW05-
based peptides with gold nanoparticles. Therefore, the modified
variants R1A3 and R2A2 of the parent peptide, as well as the
extended versions R2A3, R2A4, and R2A5, were synthesized
and characterized. In the first two cases either three or two argi-
nine residues were substituted with alanine, respectively;
alanine is not only neutral, but is also known for its high α-helix
propensity. Due to the need of an overall positive net charge of
R1A3 and R2A2 to form electrostatic interactions with the
nanoparticles, pH 9 is suitable for this study as the calculated
overall net charge is positive at this pH value. Taking into
account that the assembly of gold nanoparticles may also
depend on the length of the peptide and/or on the ratio of
presented charges per residue, peptides of greater length are
also included in this study by adding one, two, or three heptad
repeats containing alanine in their f-positions (R2A3, R2A4 and
R2A5); these were based on the sequence of R2A2 (Figure 1).
Secondary and quaternary structure of the
model peptides
Circular dichroism (CD) spectroscopy and analytical ultracen-
trifugation of VW05 at pH 9 reveals an α-helical coiled-coil
structure that consists of three monomers. Since the modifica-
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Figure 2: CD spectra of 30 µM peptide VW05, R1A3, R2A2, R2A3, R2A4 and R2A5 at (A) pH 9 and (B) pH 11 in 10 mM Tris/HCl buffer. Dynamic
light scattering of (C) VW05 and (D) R2A2 both at 15 µM at (red) pH 9 and (green) pH 11. All measurements were carried out in 10 mM Tris/HCl
buffer.
tions of the parent sequence occurred in the solvent-exposed f
position only, we expected no differences in the secondary or
quaternary structures of peptides R1A3, R2A2, R2A3, R2A4
and R2A5. CD measurements were carried out at pH 9 and
pH 11 at a final peptide concentration of 30 µM (Figure 2A/B).
The spectra confirmed that all peptides fold into α-helices as
indicated by the two characteristic minima at 208 nm and
222 nm and the maximum at 195 nm. Whereas there are no
significant differences in the CD spectra at pH 9 of R2A2,
R2A3, R2A4, and R2A5, the signal intensity of R1A3 is
dramatically decreased. Furthermore, the minimum at 222 nm is
increased and this may point to the formation of assemblies
containing α-helical fibrils. This is probably a consequence of
the formation of peptide fiber bundles which tend to precipitate
and thus decrease the concentration. In addition, the fiber
bundles may decrease the amount of peptide that is available to
generate the CD signal. Increasing the peptide concentration up
to 100 µM or incubating samples for periods up to three days do
not result in any changes in the CD spectra, indicating that there
is no concentration-dependent change in the secondary struc-
ture of the peptides. At pH 11 the CD spectra of all peptides are
virtually identical and indicate the presence of α-helical coiled-
coil structures.
Dynamic light scattering (DLS) was applied to study the
oligomerization state of the peptide variants, as analytical ultra-
centrifugation can not be used for further characterization of
peptide fibers due to extreme sample heterogeneity. Since the
oligomerization state of VW05 has been studied before [30], the
DLS spectrum of VW05 was used as a reference for all other
peptides. All measurements were performed at a sample
concentration of 15 µM at pH 9 and pH 11 because the net
charge of the peptides switches from positive to negative within
this pH range. The trimeric coiled-coil VW05 has an average
hydrodynamic diameter of approximately 3 nm (Figure 2C). As
expected from CD spectroscopy, R1A3 forms α-helical assem-
blies at pH 9 with an average size of approximately 1 µm but
appears to adopt a soluble coiled-coil structure at pH 11 because
the particle size decreases to 3 nm. Surprisingly, all other
VW05 variants form α-helical assemblies at pH 9 with average
sizes of 790 nm (R2A2), 230 nm (R2A3), 180 nm (R2A4), and
160 nm (R2A5). It seems that with increasing sequence length
the size of the peptide fibers decreases. This observation is in
agreement with a report of Ryadnov and coworkers [37]. More-
over, a second, larger species appears with a size of 1 µm. The
occurrence of two fiber species may be the result of competing
interactions between arginine residues in f-position and gluta-
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Figure 3: (A) TEM of 100 µM R2A2 in 10 mM Tris/HCl buffer, pH 9. Sample was negative stained with 2% PTA; defocus −0.5 µm. (B) Cryo TEM of
100 µm R2A2 in 10 mM Tris/HCl buffer, pH 9; defocus −1.8 µm.
mates. This can either stabilize or diminish peptide aggregation.
Increasing the pH to 11 leads to a disruption of α-helical peptide
fibers that produces coiled-coil monomers. This effect was
observed in all cases (Figure 2D).
To resolve the morphology of the quaternary structures, TEM
and/or Cryo TEM were applied to all peptides at pH 9 except
for VW05; a representative image for R2A2 is shown in
Figure 3. Negative staining TEM of 100 µM R2A2 at pH 9
demonstrates the formation of α-helical fibers. Moreover, these
fibers appear to form bundles that consist of many long and
parallel single fibers; single peptide fibers alone have not been
detected. The formed fiber bundles appear to be very rigid in
their structure as they appear only as straight and long fibers
with a length ranging from several 100 nm up to more than
1 µm. The average diameter of one single fiber is 2.5–3 nm.
One single helix has a diameter of 0.5–1 nm, thus one fiber
presumably consists of multiple coiled-coil trimers. On the
other hand, even single peptide fibers were observed using Cryo
TEM; however, they seem to be much shorter in length.
However, resolving the microstructure of one fiber bundle using
Cryo TEM was not possible. Surprisingly, fiber bundles could
not be observed for peptides R2A4 and R2A5 whose sequences
were extended by either two or three heptad repeats. It must be
concluded that sample drying and the addition of a staining
reagent has an effect on the final fiber structure.
Peptide-induced nanoparticle assembly
The absorption maximum of the LSPR band is a size-depen-
dent property of a gold nanoparticle: the greater the size of the
gold nanoparticle, the more red-shifted its absorption
maximum. When numerous smaller gold nanoparticles get into
close proximity due to aggregation they behave as one larger
gold nanoparticle the electronic properties of which can be
monitored by the red-shift and broadening of the absorption
maximum of the LSPR band. UV–vis absorption spectroscopy
was applied to monitor the LSPR band of mercaptoundecanoic
acid-functionalized gold nanoparticles (Au/MUA) in the pres-
ence of the VW05 variants. Peptides at concentrations ranging
from 5 to 30 µM, at pH 9, were added to a nanoparticle solu-
tion and UV–vis absorption measurements were carried out. To
determine the time-dependence of the assembly process, all
measurements were repeated at a three hour time point and a
three day time point.
The nanoparticles used in this project were synthesised
according to the literature and subsequently refunctionalized in
a ligand exchange reaction with mercaptoundecanoic acid
[38,39]. The obtained Au/MUA nanoparticles have an average
diameter of 5.5 nm, as determined by TEM, and are monodis-
perse, as confirmed by DLS. An absorption maximum of
525 nm is observed for the Au/MUA nanoparticles in the
absence of peptide, even over an incubation time of three days.
After addition of the peptide R1A3, only a negligible red-shift
of 0.5 nm of the absorption maximum is detected (Figure 4E).
Neither an extended incubation time of three days nor an
increase in the concentration of the applied peptide to 30 µM
leads to a significant increase in the red-shift. This result
sharply contrasts with that of the VW05 parent peptide, indi-
cating that the absence of a red-shift and thus a lack of nanopar-
ticle aggregation is very likely a consequence of the reduced
number of presented arginine residues in the f-positions of
R1A3 compared to VW05. Thus this observation implies that
either R1A3 does not interact with Au/MUA nanoparticles or
that its interactions are not strong enough to bring the nano-
particles into close proximity to induce a red-shift. Probably the
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Figure 4: (A) Dynamic light scattering of 0.05 µM Au/MUA nanoparticles at pH 9. (B) Cryo TEM image of 0.05 µM Au/MUA nanoparticles at pH 9. (C)
UV–vis spectra of 0.05 µM Au/MUA nanoparticles at pH 9 and in the presence of 30 µM VW05. (D) Time and concentration dependent shift in the
absorption maximum of 0.05 µM Au/MUA nanoparticles in the presence of different amounts of R2A2. (E) Time-dependent shift in the absorption
maximum at a fixed peptide concentration of 30 µM.
distance between two arginine residues is insufficient for an
interaction, which was later on proven by the lack of changes in
the secondary structure of peptide R1A3. Accordingly, an
increase in the number of arginine residues at f-positions to two
in case of R2A2 leads to a significant shift of the LSPR band of
1.20 to 3.75 nm (Figure 4D). As shown in Figure 4D, these red-
shifts increase with the peptide concentration as well as with the
incubation time; for example, at a concentration of 30 µM of
R2A2 the absorption maximum changes by 3.75 nm to 9.80 nm
over three days. Although the observed red-shift is minor
compared to the parent peptide VW05 at an equal peptide
concentration, it can be assumed that incubation with R2A2
leads to an aggregation of Au/MUA nanoparticles. A stepwise
increase in the sequence length by adding one heptad repeat
without changing the amount of arginine residues (R2A3) leads
to a comparable effect (Figure 4E). In contrast, increasing the
incubation time to three days does not change the red-shift
significantly (Figure 4E); for example, the measured red-shift is
3.75 nm after adding the peptide and 4.70 nm after three days.
Adding yet another heptad repeat to the sequence to yield R2A4
affects nanoparticle assembly only marginally, since there is no
significant change in the LSPR band compared to R2A3. Even
after an incubation time of three days the difference in the red-
shift is less than 0.5 nm. Nevertheless, a peptide-induced
assembly can be discussed for both peptides. On the other
hand, a further increase in the peptide length (R2A5) has a
significant effect on the observed LSPR band and thus on
nanoparticle aggregation. The determined red-shift of 1 nm is
very similar to the observed shift of 0.5 nm for R1A3 measured
immediately after adding the peptide. With increasing incuba-
Beilstein J. Org. Chem. 2015, 11, 792–803.
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Figure 5: CD spectra of 15 µM peptide in the presence 0.05 µM Au/MUA nanoparticles at pH 9 after (A) 0 hours and (B) three hours.
tion time the absorption maximum is slightly shifted but even
after three days the value is only half of those measured for
R2A3 and R2A4.
It is known that gold nanoparticles may affect the secondary
structure of a peptide or protein [33]. To investigate the effect
of Au/MUA nanoparticles on the secondary structure of the
peptides included in this study, CD spectroscopy was applied
with a peptide concentration of 15 µM and 0.05 µM Au/MUA
nanoparticle concentration. The obtained CD spectra of VW05
show a strong decrease in signal intensity immediately after the
addition of Au/MUA nanoparticles (Figure 5A). This can be
explained by the almost complete immobilization of the peptide
on the nanoparticle surface in multiple layers. Thus, the concen-
tration of dissolved peptide is dramatically decreased and a CD
signal can not be detected anymore. A similar effect could be
described by Calzolai and coworkers using silver nanoparticles
[40]. Furthermore, the minimum at 222 nm increases compared
to the minimum at 208 nm which can be attributed to the forma-
tion of α-helical fibers. Extending the incubation time to three
hours leads to an almost complete loss in the signal intensity of
peptide VW05. Peptides R2A2, R2A3, and R2A4 show a some-
what similar effect after incubation with Au/MUA nano-
particles. A decrease in signal intensity as well as an increase in
the minimum at 222 nm is observed, although the loss of inten-
sity is not as strong as that observed for VW05. This observa-
tion can be attributed to the accumulation of VW05 on the
surface of the nanoparticles, whereas the variants form fibrils
and do not accumulate in the same way. However, the CD
spectra remain stable and no further decrease in the signal inten-
sity is observed during a longer incubation time. CD measure-
ments of R1A3, which induced no red-shift of Au/MUA nano-
particles, reveal no significant structural changes due to
nanoparticle addition.
Agarose gel electrophoresis was used to evaluate whether a
peptide–nanoparticle interaction takes place. Au/MUA nano-
particles show a band of relatively high electrophoretic mobility
at pH 9, and the addition of only 5 µM VW05 leads to a
complete loss in mobility of Au/MUA nanoparticles (Figure 6).
On the other hand, the mobility of the Au/MUA nanoparticle
band only slightly decreases when R1A3 is present; even a very
high concentration of peptide R1A3 (200 µm) does not change
this finding. All other peptides cause a stepwise decrease in
Au/MUA nanoparticle mobility in a concentration-dependent
manner. A peptide concentration of 100 µM is necessary to
completely abolish electrophoretic mobility. To monitor the
position of the peptide band next to Au/MUA nanoparticles and
the presence of unbound peptide, the agarose gel was visu-
alised by UV light at a wavelength of 254 nm. While an elec-
trophoretic mobility of VW05 could be detected only for a high
peptide concentration of 100 µM, the peptide band of R1A3 did
not show any mobility. This effect could be explained by the
formation of α-helical fibrils (vide infra) that are not able to
enter the pores of the gel. The absence of a peptide band at
5 µM R1A3 is presumably due to the limited sensitivity of this
technique. In contrast, R2A2 and all analogues with extended
peptide length (see Supporting Information File 1) show a well-
defined peptide band at a concentration of 10 µM with inten-
sities increasing with peptide concentration.
Isothermal titration calorimetry (ITC) was used to determine the
thermodynamic parameters as well as the binding constant for
the assembly of Au/MUA nanoparticles (Table 1). By fitting
with a one set of binding site mode the binding stoichiometry N,
the binding constant KB, and the enthalpy ΔH can be directly
obtained from the measured data whereas the entropy ΔS is
calculated.
Due to very weak or absent interactions of R1A3 or R2A5 with
Au/MUA nanoparticles it was not possible to determine thermo-
dynamic parameters. Surprisingly, the obtained binding
constants are not in accordance with the observations made
based on the UV–vis measurements. The shift in the absorption
maximum obtained from UV–vis measurements for R2A2 is
much smaller than that of VW05, but its binding constant of
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Figure 6: Agarose gel of (A) VW05, (B) R1A3, and (C) R2A2 in the presence of 0.05 µM Au/MUA nanoparticles at pH 9 visualised by UV light (left)
and visible light (right).
Table 1: Thermodynamic parameters for the aggregation of Au/MUA nanoparticles with peptides VW05, R2A2, R2A3, and R2A4 obtained by ITC.
N KB [105 M−1] ΔH [kcal mol−1] ΔS [cal deg mol−1]
VW05 20.2 ± 1.6 5.3 ± 1.7 3.5 ± 0.4 38
R2A2 17.9 ± 0.4 18.2 ± 5.9 −7.3 ± 0.2 5.8
R2A3 18.8 ± 1.4 6.3 ± 1.8 −4.9 ± 0.5 9.7
R2A4 17.3 ± 1.8 2.5 ± 0.8 −3.9 ± 0.5 11.5
18.2 . 105 M−1 is about 3.5-fold higher than that of VW05,
although the amount of presented charges is reduced in R2A2.
The stepwise increase in peptide length induced a dramatic
decrease of the KB value. However, the KB of R2A3 is slightly
higher compared to VW05. Only a further increase in peptide
length lead to a significant decrease in the binding constant
compared to VW05. Although gel electrophoresis revealed a
remarkable difference in the binding stoichiometry of VW05
versus R2A2 and its longer analogues, the binding stoichiom-
etry is similar in all cases. The greatest N value is observed for
the parent peptide VW05. Furthermore, major differences were
observed with regard to the molar binding energy ΔH. First of
all a positive molar binding energy for VW05 was determined
while this was found to be negative for R2A2, R2A3, and
R2A4. This can be explained by the different quaternary struc-
ture of peptides R2A2, R2A3, and R2A4 compared to VW05.
The latter forms coiled-coil trimers that are refolded into
α-helical fibers in the presence of Au/MUA nanoparticles,
whereas R2A2 and its analogues are already present as fibers
before interacting with nanoparticles, which results in a nega-
tive molar binding energy. The molar binding energy of these
peptides can be directly correlated with their binding constants,
as, for example, R2A2 shows the highest binding affinity,
produces the greatest release of energy and has the smallest
binding energy. With increasing peptide length, the binding
affinity decreases, as does the release of energy, which is indi-
Beilstein J. Org. Chem. 2015, 11, 792–803.
800
Figure 7: Cryo TEM images of 100 µM R2A2 and 0.05 µM Au/MUA nanoparticles at pH 9 at a defocus of (A) −1.2 µm, (B) −1.8 µm and (D) after pH
switch from 11 to 9 at a defocus of −1.8 µm. (C) Cryo TEM images of 100 µM R2A2 and 0.4 µM Au/MUA nanoparticles at pH 9 at a defocus of
−1.8 µM.
cated by the increase in molar binding energy. Nevertheless, all
peptide–nanoparticle interactions are entropically favored
processes as entropy increases with along with binding energy.
Morphological studies of peptide-induced
nanoparticle assemblies
Cryo TEM was used to gain insight into the morphology of the
peptide–nanoparticle aggregates. The concentration of peptide
in all samples was 100 µM. It was already known that VW05
induces the aggregation of Au/MUA nanoparticles in a very
disordered fashion. In the case of the modified analogues of
VW05, the Au/MUA nanoparticles assemble in a completely
different way. As can be seen in Figure 7A the nanoparticles are
almost exclusively organized at the surface of the peptide fiber
bundles. A similar effect was reported by Cherny and
coworkers [41]. Since the nanoparticle concentration was
0.05 µM, an excess of peptide was present in solution. Thus it
was expected that Au/MUA nanoparticles would be equally
distributed on the surface of the peptide fibers. However, the
nanoparticles were found to accumulate on the surface of larger
fiber bundles, whereas some fiber bundles and especially
single-peptide fibers remain unbound (Figure 7b). Upon
increasing the nanoparticle concentration to 0.4 µM, unbound
peptide could not be detected anymore whereas single and
unbound nanoparticles are observed (Figure 7c). The obtained
assemblies show a highly ordered adsorption of nanoparticles
on the surface of the fiber in a three dimensional manner, which
was supported by stereo Cryo TEM. Nevertheless, the decora-
tion of peptides fibers with gold nanoparticles could only be
observed for peptides that form fiber bundles. Peptides R2A4
and R2A5, which did not show bundle formation, led to a
unordered nanoparticle aggregation comparable to those of
VW05. Obviously, the single peptide fibers are more flexible
and can surround the nanoparticles.
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Table 2: List of amino acid to arginine ratios for the sequences investigated here.
amino acid residues arginine residues amino acids/arginine ratio
VW05 26 4 6.5
R1A3 26 1 26
R2A2 26 2 13
R2A3 33 2 16.5
R2A4 40 2 20
R2A5 47 2 23.5
To evaluate whether the observed morphology is a result of the
presence of peptide fibers even before the addition of nanopar-
ticle, the pH of the peptide nanoparticle mixture was increased
to pH 11 (Figure 7d). As previously reported for VW05 the
change in pH results in disruption of the fibers and coiled-coil
peptides are formed again. A subsequent decrease of the pH to 9
led to a dramatic change in the morphology of the
peptide–nanoparticle assemblies. Whereas long and relatively
thin nanoparticle-decorated fibers were observed prior to the
change in pH, shorter and significantly brighter assemblies were
obtained afterwards. However, even these assemblies do not ex-
hibit the high level of organisation of nanoparticles on the fiber
surface that had been previously observed. Moreover, a fully
disordered nanoparticle accumulation was detected. These
aggregates may be formed due to coiled-coil structures of the
peptides since they appear to be very similar to those observed
for VW05.
Discussion
We have studied the effect of peptide length and net charge of
coiled-coil-based sequences on their interaction with Au/MUA
nanoparticles. Five analogues of the previously reported peptide
VW05 were generated (Table 2) to study peptide-induced
nanoparticle aggregation caused by electrostatic interactions.
Due to the different number of presented arginine residues and
length of the peptides the aggregation tendency and morphology
of nanoparticles was modified. Peptide R1A3 presents one
arginine residue in an f-position per 26-mer and was not effi-
cient in interacting with nanoparticles. Peptides R2A2, R2A3,
R2A4 and R2A5 efficiently interact with nanoparticles,
although increasing the peptide length leads to a decrease in
peptide–nanoparticle interactions as observed in lower binding
affinities and reduced red-shifts of the absorption maximum.
Obviously, a ratio of peptide length to presented charges not
higher than 23.5 is required for specific interactions between
coiled-coil peptides and nanoparticles.
Furthermore, the quaternary structure of the initial peptide plays
an important role in nanoparticle assembly and the final
morphology of nanoparticle–peptide aggregates. Whereas
coiled-coil-forming peptides cause a more disordered nanopar-
ticle assembly, fiber-forming peptides induce a well defined
accumulation of the nanoparticles on their surface. Surprisingly,
nanoparticles aggregate on the surface of larger fiber bundles
but do not do so on single fibers. This may be the case because
the amount of arginine residues in a single peptide fiber is
insufficient to interact with nanoparticles. In addition, peptide
fiber bundles were observed that do not have any nanoparticles
attached to their surface. Apparently there is an unequal
assembly of nanoparticles on the surface of the peptides.
The presence of preassembled peptide fibers has important
consequences for the binding stoichiometry, the binding
constant, and the molar binding energy of peptide–nanoparticle
aggregation. Gel electrophoresis reveals a significant popula-
tion of unbound peptide for R2A2, R2A3, and R2A4 at a
peptide concentration of 10 µM, whereas a concentration of
100 µM of VW05 is required to observe unbound peptide.
Nevertheless, peptide VW05 and its analogues have almost the
same binding stoichiometry determined by ITC. This can be
explained by considering the following points. Due to the fibril
formation of R2A2, R2A3, and R2A4 Au/MUA nanoparticles
interact with distinct positions on the surface of the peptide
fiber. Cryo TEM images reveal, that an excess of peptide
remains unbound in solution. In contrast, a coiled-coil peptide
directly covers the nanoparticle surface and causes the assembly
of two or more nanoparticles. Moreover the nanoparticles are
covered with multiple peptide layers which is an ongoing
process. In addition, the high local peptide concentration leads
to α-helical fibril formation. As gel electrophoresis was carried
out after an incubation time of 30 min, an excess of peptide
could either bind to the nanoparticle surface or form fibrils.
Thus, a higher binding stoichiometry is obtained by gel elec-
trophoresis.
The differences in the quaternary structures of the peptides also
lead to an unexpected observation in the binding constant data.
Due to the greater number of arginine residues in VW05 it was
expected that VW05 would have the highest binding constant.
In fact the binding constant is 3.5-fold smaller compared to
R2A2 and even the binding constant of R2A3 is slightly higher.
Therefore it can be assumed that the fiber formation increases
Beilstein J. Org. Chem. 2015, 11, 792–803.
802
the binding constant significantly (Table 1). Compared to
coiled-coil oligomers the α-helical peptide fiber has a highly
ordered structure and the charge density is well localized on the
surface of the fiber. Thus, the peptide nanoparticle interactions
are more efficient due to direct interactions of nanoparticles
with the surface of the fibers without any changes in the peptide
structure. On the other hand, the peptide VW05 covers the
surface of the nanoparticle, which results in an aggregation of
the nanoparticles as well as a α-helical fiber formation of
VW05. The latter one is a result of the high local peptide
concentration on the surface of nanoparticles. However, peptide
refolding reduces the binding constant KB. Thus, a well-defined
peptide structure is crucial for increasing the binding constant.
On the other hand, a larger number of arginine residues is not a
prerequisite for increasing the binding constant.
Furthermore, the molar binding energies of the fiber forming
peptides R2A2, R2A3, and R2A4 are different compared to the
coiled-coil peptide VW05. In principle it can be assumed that
the electrostatic interaction of peptide and nanoparticle is a
reaction that releases heat which is indicated by a negative
binding energy. Thus, the interaction between nanoparticle and
fiber-forming peptide results in a negative binding energy
which decreases along with the binding constant. During the
VW05-induced aggregation of nanoparticles two reactions take
place: 1) peptide-induced nanoparticle assembly, and 2)
refolding of the coiled-coil peptide into α-helical fibers. But
whereas the former is an exothermic reaction, the latter is an
endothermic reaction: due to the fiber formation the coiled-coil
structure has to be dissolved into single random-coil peptides.
This is an energetically disfavoured process. Apparently the
energy that is needed for dissolving the coiled-coil is higher
than the energy that is delivered due to nanoparticle assembly
and refolding into α-helical fibers. Thus, the whole reaction is
endothermic.
Moreover, a pH switch has a dramatic effect on the observed
nanoparticle assembly for the peptide–nanoparticle aggregates
of R2A2, R2A3, and R2A4. Increasing the pH value to 11
causes a refolding of the peptide fibers into a coiled-coil struc-
ture. A subsequent decrease to pH 9 results in two concomitant
reactions: the formation of peptide fibers and the nanoparticle
aggregation. Cryo TEM reveals that both reactions occur
approximately with the same reaction rates: on the one hand
short and bright nanoparticle assemblies are detected that are
presumably formed due to peptide fibers. On the other hand
nanoparticle assemblies are observed that are very similar to
those obtained for VW05 [32]. Apparently the nanoparticle
decoration on the surface of the peptides is an intrinsic property
of the fiber.
Conclusion
The results presented herein demonstrate that the aggregation of
Au/MUA nanoparticles depends not only on the number of
presented arginine residues but also on the sequence length. The
peptides studied here require a ratio not higher than 23.5 to
specifically interact with oppositely charged nanoparticles.
Thus the size of the peptide and finally the charge density plays
an important role for its aggregation efficiency.
Furthermore, we could show that the quaternary structure of the
peptide has important consequences for the formed nanopar-
ticle assemblies, as well as for the thermodynamics of aggrega-
tion. First of all a peptide fiber leads to a well-defined nanopar-
ticle aggregation on the surface, whereas soluble coiled-coil or
random-coil peptides induce either an unstructured aggregation,
or, in the case of random-coil peptides, no aggregation at all.
Secondly, the peptide fiber with its well-defined presentation of
charges causes an increase in the binding constant as well as in
the binding energy. Thus, even a peptide with a lower number
of charges can induce more rapid aggregation of nanoparticles
if the peptide forms fibers. In contrast, nanoparticle aggrega-
tion induced by coiled-coil peptides even with a higher number
of charges occurs more slowly.
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